• HOME
  •  > 
  • 医学一般
  •  > 
  • 雑誌
  •  >  別冊・医学のあゆみ　バイオインフォマティクスの世界

別冊・医学のあゆみ　バイオインフォマティクスの世界

出版社： 医歯薬出版
発行日： 2023-03-15
分野： 医学一般  >  雑誌
ISSN： 00392359
雑誌名：
特集： バイオインフォマティクスの世界
電子書籍版： 2023-03-15 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,170 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,170 円(税込)

購入する

目次

  • 特集　バイオインフォマティクスの世界

    1．ゲノム解析におけるバイオインフォマティクスの役割
    2．トランスクリプトームデータの一般的な解析手順
    3．プロテオミクスと質量分析─疾患の現場にいたのはどの遺伝子だ?
    4．マイクロバイオームと臨床メタプロテオミクス：共棲細菌がチームで働く仕組みの解明
    5．メタボロミクスにおける「質量分析インフォマティクス」
    6．グライコインフォマティクス（糖鎖インフォマティクス）
    7．バイオインフォマティクスの根幹を担うデータベース
    8．疾患ゲノム解析I：NGS解析
    9．疾患ゲノム解析II：GWAS解析
    10．機械学習による薬物応答トランスクリプトームの解析と疾患治療薬の探索
    11．画像診断用人工知能─コンピュータ支援診断（CAD）
    12．臨床におけるバイオインフォマティクス
    13．プレシジョン・メディシンI─がんゲノム医療
    14．プレシジョン・メディシンII─がんゲノミクスの応用
    15．やってみようバイオインフォマティクス─SNP解析編
    16．やってみようバイオインフォマティクス─RNA-seq解析編
    17．やってみようバイオインフォマティクス─メタ16S解析編
    18．やってみようバイオインフォマティクス─エンリッチメント解析編

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1. ゲノム解析におけるバイオインフォマティクスの役割

P.8 掲載の参考文献
1) Sanger F et al. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74(12):5463-7.
PubMed
2) Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci USA 1977;74(2):560-4.
 
3) Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-50.
 
4) Fleischmann R et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995;269(5223):496-512.
PubMed
5) Goffeau A et al. Life with 6000 genes. Science 1996;274(5287):546-67.
PubMed
6) Blattner FR et al. The complete genome sequence of Esch-erichia coli K-12. Science 1997;277(5331):1453-62.
 
7) Kunst F et al. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 1997;390(6657):249-56.
PubMed
8) The C. elegans Sequencing Consortium. Genome sequence of the nematode C. elegans:a platform for investigating biology. Science 1998;282(5396):2012-8.
 
9) Venter JC et al. The sequence of the human genome. Sci-ence 2001;291(5507):1304-51.
 
10) Lander ES et al. Initial sequencing and analysis of the human genome. Nature 2001;409(6822):860-921.
PubMed
11) Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26(19):2460-1.
 

2. トランスクリプトームデータの一般的な解析手順

P.14 掲載の参考文献
1) Hendrickson PG et al. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons. Nat Genet 2017;49:925-34.
PubMed
2) Dobin A et al. STAR:Ultrafast universal RNA-seq aligner. Bioinformatics 2013;29:15-21.
PubMed
3) Kim D et al. Graph-based genome alignment and genotyp-ing with HISAT2 and HISAT-genotype. Nat Biotechnol 2019;37:907-15.
 
4) Frankish A et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res 2019;47:D766-73.
PubMed
5) Liao Y et al. FeatureCounts:An efficient general purpose program for assigning sequence reads to genomic fea-tures. Bioinformatics 2014;30:923-30.
 
6) Robinson MD et al. edgeR:a Bioconductor package for dif-ferential expression analysis of digital gene expression data. Bioinformatics 2010;26:139-40.
 
7) Tohonen V et al. Novel PRD-like homeodomain transcription factors and retrotransposon elements in early human devel-opment. Nat Commun 2015;6:8207.
 

3. プロテオミクスと質量分析 - 疾患の現場にいたのはどの遺伝子だ ?

P.21 掲載の参考文献
1) Aslam B et al. Proteomics:Technologies and Their Applica-tions. J Chromatogr Sci 2017;55:182-96.
 
2) Macklin A et al. Recent advances in mass spectrometry based clinical proteomics:applications to cancer research. Clin Proteomics 2020;17:17.
PubMed
3) Corey KE et al. ADAMTSL2 protein and a soluble biomarker signature identify significant and advanced fibrosis in adults with NAFLD. J Hepatol2021.(in press)
 
4) Mao L et al. Proteomic analysis of lung cancer cells reveals a critical role of BCAT1 in cancer cell metastasis. Theranos-tics 2021;11:9705-20.
 
5) Soh WT et al. ExteNDing Proteome Coverage with Legumain as a Highly Specific Digestion Protease. Anal Chem 2020;92:2961-71.
PubMed
6) Smith JC et al. Chapter5:Modern techniques in quantitative proteomics. Advanced LC-MS applications for proteomics(Pennington SR ed), Newlands Press;2019.
 
7) Craig R, Beavis RC. TANDEM:matching proteins with tan-dem mass spectra. Bioinformatics 2004;20:1466-7.
 
8) Perkins DN et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
PubMed
9) Tyanova S et al. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 2016;11:2301-19.
PubMed
10) Kim S, Pevzner PA. MS-GF+ makes progress towards a universal database search tool for proteomics. Nat Com-mun 2014;5:5277.
 
11) Geer LY et al. Open mass spectrometry search algorithm. J Proteome Res 2004;3:958-64.
PubMed
12) Vaudel M et al. SearchGUI:An open-source graphical user interface for simultaneous OMSSA and X!Tandem searches. Proteomics 2011;11:996-9.
 
13) Potel CM et al. Phosphopeptide Fragmentation and Site Localization by Mass Spectrometry:An Update. Anal Chem 2019;91:126-41.
PubMed
14) Riley NM et al. Optimal Dissociation Methods Differ for N-and O-Glycopeptides. J Proteome Res 2020;19:3286-301.
 
15) Mantini G et al. Computational Analysis of Phosphopro-teomics Data in Multi-Omics Cancer Studies. Proteomics 2021;21:e1900312.
 
16) Mertins P et al. Proteogenomics connects somatic mutations to signaling in breast cancer. Nature 2016;534:55-62.
PubMed
17) Sakabe K, Hart GW. O-GlcNAc入門. Glyco Forum. 2005;9:A2.
 
18) Ferrer CM et al. O-GlcNAcylation in Cancer Biology:Linking Metabolism and Signaling. J Mol Biol 2016;428:3282-94.
PubMed
19) Ma J et al. O-GlcNAcAtlas:A database of experimentally identified O-GlcNAc sites and proteins. Glycobiology 2021;31:719-23.
PubMed
20) Wulff-Fuentes E et al. The human O-GlcNAcome database and meta-analysis. Scientific Data 2021;8:25.
 
21) Cao L et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 2021;184:5031-52.
PubMed

4. マイクロバイオームと臨床メタプロテオミクス : 共棲細菌がチームで働く仕組みの解明

P.29 掲載の参考文献
1) Wang Y et al. Metaproteomics:A strategy to study the tax-onomy and functionality of the gut microbiota. J Proteomics 2020;219:103737.
 
2) Sender R et al. Are We Really Vastly Outnumbered? Revisit-ing the Ratio of Bacterial to Host Cells in Humans. Cell 2016;164:337-40.
 
3) Arimatsu K et al. Oral pathobiont induces systemic inflam-mation and metabolic changes associated with alteration of gut microbiota. Sci Rep 2014;4:4828.
 
4) Serrano-Villar S et al. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals. EBioMedi-cine 2016;8:203-16.
 
5) Zhang X et al. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle pro-teins in pediatric inflammatory bowel disease. Nat commun 2018;9:2873.
 
6) Debyser G et al. Faecal proteomics:A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis. J Cyst Fibros 2016;15:242-50.
 
7) Hickl O et al. Sample preservation and storage significantly impact taxonomic and functional profiles in metaproteomics studies of the human gut microbiome. Microoganisms 2019;7:367.
 
8) Garcia-Duran C et al. Distinct human gut microbial taxo-nomic signatures uncovered with different sample process-ing and microbial cell disruption methods for metapro-teomic analysis. Front Microbiol 2021;12:618566.
 
9) 三浦信明. メタプロテオミクスとバイオインフォマティクス解析における課題. Proteome Letters 2021;6:27.
 
10) Qin J et al. A human gut microbial gene catalogue estab-lished by metagenomic sequencing. Nature 2010;464:59-65.
 
11) The Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012;486:215-21.
 
12) Li J et al. An integrated catalog of reference genees in the human gut microbiome. Nat Biotechnol 2014;32:834-41.
 
13) Zou Y et al. 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses. Nat Biotechnol 2019;37:179-85.
 
14) Browne H P et al. Culturing of 'unculturable' human micro-biota reveals novel taxa and extensive sporulation. Nature 2016;533:543-6.
 
15) Forster SC et al. A human gut bacterial genome and culture collection for improved metagenomic analyses. Nat Biotech 2019;37:186-92.
 
16) Almeida A et al. A unified catalog of 204,938 reference genomes from the human gut microbiome. Nat Biotechnol 2021;39:105-14.
 
17) Nishijima S et al. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res 2016;23:125-33.
 
18) Liao B et al. iMetaLab 1.0:a web platform for metapro-teomics data analysis. Bioimformatics 2018;34:3954-6.
 
19) Verschaffelt P et al. Unipept Desktop:A Faster, More Power-ful Metaproteomics Results Analysis Tool. J Proteome Res 2021;20:2005-9.
 
20) Mesuere B et al. High-throughput metaproteomics data analysis with Unipept:A tutorial. J Proteomics 2018;171:11-22.
 

5. メタボロミクスにおける「質量分析インフォマティクス」

P.37 掲載の参考文献
1) Smith CA et al. XCMS:processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006;78(3):779-87.
PubMed
2) Tautenhahn R et al. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinform 2008;9:504.
 
3) Sugimoto M et al. Bioinformatics Tools for Mass Spectros-copy-Based Metabolomic Data Processing and Analysis. Curr Bioinform 2012;7(1):96-108.
 
4) 山本博之. 第5章2節メタボロームデータベースの構築の現状と創薬応用. in silico 創薬におけるスクリーニングの高速化・高精度化技術(技術情報協会). 技術情報協会;2018,p.383-91.
 
5) Tsugawa H et al. Hydrogen Rearrangement Rules:Computational MS/MS Fragmentation and Structure Eluci-dation Using MS-FINDER Software. Anal Chem 2016;88(16):7946-58.
 
6) Yamamoto H, Sasaki K. Metabolomics-based approach for ranking the candidate structures of unidentified peaks in capillary electrophoresis time-of-flight mass spectrometry. Electrophoresis 2017;38(7):1053-9.
PubMed
7) Duhrkop K et al. SIRIUS4:Turning tandem mass spectra into metabolite structure information. Nat Methods 2019;16:299-302.
 
8) Tsugawa H et al. MS-DIAL:data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods 2015;12:523-26.
 
9) Pluskal T et al. MZmine2:modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform 2010;11:395.
 
10) Pang Z et al. MetaboAnalyst5.0:narrowing the gap between raw spectra and functional insights. Nucl Acids Res 2021;49(W1):W388-W396.
 
11) 山本博之. 実践編(3)多変量解析, エンリッチメント解析, 代謝マップ描画. メタボロミクス実践ガイド(馬場健史・他). 羊土社;2021, p.224-36.
 
12) Junker BH et al. VANTED:a system for advanced data analy-sis and visualization in the context of biological networks. BMC Bioinform 2006;7:109.
 
13) Yamamoto H. PLS-ROG:Partial least squares with rank order of groups. J Chemom 2017;31(3):e2883.
 
14) Yamamoto H. Statistical hypothesis testing of factor loading in principal component analysis and its application to metabolite set enrichment analysis. BMC Bioinform 2014;15(1):51.
 
15) Yamamoto H. OS-PCA:Orthogonal Smoothed Principal Component Analysis Applied to Metabolome Data. Metabo-lites 2021;11(3):149.
 
16) Dunn WB. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060-83.
PubMed
17) Want EJ. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc 2013;8:17-32.
PubMed
18) Yamamoto H et al. Capillary Electrophoresis Mass Spec-trometry-Based Metabolomics of Plasma Samples from Healthy Subjects in a Cross-Sectional Japanese Population Study. Metabolites 2021;11(5):314.
 
19) Izumi Y et al. Inter-laboratory comparison of metabolite measurements for metabolomics data integration. Metabo-lites 2019;9:257.
 

6. グライコインフォマティクス ( 糖鎖インフォマティクス ) 38

P.44 掲載の参考文献
1) Varki A et al. Essentials of Glycobiology, Third Edition. Cold Spring Harbor Laboratory Press;2017.
 
2) Sharon N. Eur J Biochem 1986;159(1):1-6.
PubMed
3) Matsubara M et al. J Chem Inf Model 2017;57(4):632-7.
PubMed
4) Neelamegham S et al. Glycobiology 2019;29(9):620-4.
PubMed
5) Mehta AY, Cummings RD. Bioinformatics 2020;36(11):3613-4.
PubMed
6) SNFG Edit. CSDB/SNFG Structure Editor.(http://csdb.glycoscience.ru/snfgedit/snfgedit.html?expert=0&destination=structure)
 
7) SugarSketcher.(https://glycoproteome.expasy.org/sugarsketcher/)
 
8) Huang YF et al. Dev Cell 2021;56(8):1195-209.e7.
 
9) Yamada I et al. Nat Methods 2020;17(7):649-50.
PubMed
10) Konishi Y, Aoki-Kinoshita, KF. Bioinformatics 2012;28(21):2849-50.
PubMed
11) Raman R et al. Glycobiology 2006;16(5):82R-90R.
PubMed
12) Yamakawa N et al. Nat Commun 2018;9(1):4647.
PubMed
13) Natsuka S et al. PLoS One 2014;9(7):e102219.
PubMed
14) Fujita A et al. Nucleic Acids Res 2021;49(D1):D1529-33.
PubMed
15) Ranzinger R, York WS. Methods Mol Biol 2015;1273:109-24.
PubMed
16) Watanabe Y et al. Nucleic Acids Res 2021;49(D1):D1523-8.
PubMed
17) Rojas-Macias MA et al. Nat Commun 2019;10(1):3275.
PubMed
18) York WS et al. Glycobiology 2020;30(2):72-3.
PubMed
19) Alocci D et al. J Proteome Res 2019;18(2):664-77.
PubMed
20) Aoki-Kinoshita KF et al. Glycobiology 2020;30(2):70-1.
PubMed
21) Solovieva E et al. J Biomed Semantics 2018;9(1):14.
PubMed
22) Pinero J et al. Database 2015;bav028.
PubMed
23) Alliance of Genome Resources Consortium. Nucleic Acids Res 2020;48(D1):D650-8.
 
24) Fabregat A et al. Nucleic Acids Res 2018;46(D1):D649-55.
PubMed
25) Oki S et al. EMBO Rep 2018;19(12):e46255.
 
26) Kelly SM et al. Front Microbiol 2021;12:609418.
PubMed

7. バイオインフォマティクスの根幹を担うデータベース

P.50 掲載の参考文献
1) Clark K et al. GenBank. Nucleic Acids Res 2016;44:D67-72.
PubMed
2) O'Leary NA et al. Reference sequence(RefSeq)database at NCBI:current status, taxonomic expansion, and functional annotation. Nucleic Acids Res 2016;44:D733-45.
PubMed
3) Kanehisa M et al. KEGG:integrating viruses and cellular organisms. Nucleic Acids Res 2021;49:D545-51.
PubMed
4) Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26(19):2460-1.
 
5) Kent WJ. BLAT---the BLAST-like alignment tool. Genome Res 2002;12(4):656-64.
PubMed
6) Suzuki S et al. GHOSTX:an improved sequence homology search algorithm using a query suffix array and a database suffix array. PLoS One 2014;9(8):e103833.
 
7) Karp PD et al. The BioCyc collection of microbial genomes and metabolic pathways. Brief Bioinform 2019;20(4):1085-93.
PubMed
8) Fabregat A et al. The reactome pathway knowledgebase. Nucleic Acids Res 2018;46(D1):D649-55.
PubMed
9) Yamada T et al. iPath2.0:interactive pathway explorer. Nucleic Acids Res 2011;39:W412-5.
 
10) Leinonen R et al. The sequence read archive. Nucleic Acids Res 2011;39:D19-21.
PubMed
11) Leinonen R et al. The European Nucleotide Archive. Nucleic Acids Res 2011;39:D28-31.
PubMed
12) Kodama Y et al. The Sequence Read Archive:explosive growth of sequencing data. Nucleic Acids Res 2012;40:D54-6.
PubMed
13) Barrett T et al. NCBI GEO:archive for functional genomics data sets--update. Nucleic Acids Res 2013;41:D991-5.
PubMed
14) Kolesnikov N et al. ArrayExpress update--simplifying data submissions. Nucleic Acids Res 2015;43:D1113-6.
PubMed
15) Kodama Y et al. DDBJ update:the Genomic Expression Archive(GEA)for functional genomics data. Nucleic Acids Res 2019;47:D69-73.
PubMed
16) UniProt Consortium. UniProt:the universal protein knowl-edgebase in 2021. Nucleic Acids Res 2021;49:D480-9.
 
17) Vizcaino JA et al. ProteomeXchange provides globally coor-dinated proteomics data submission and dissemination. Nat Biotechnol 2014;32(3):223-6.
 
18) Vizcaino JA et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 2016;44:D447-56.
PubMed
19) Okuda S et al. JPOSTrepo:an international standard data repository for proteomes. Nucleic Acids Res 2017;45:D1107-11.
PubMed
20) Horai H et al. MassBank:a public repository for sharing mass spectral data for life sciences. J Mass Spectrom 2010;45(7):703-14.
PubMed
21) Aoki-Kinoshita K et al. GlyTouCan 1.0--The international glycan structure repository. Nucleic Acids Res 2016;44:D1237-42.
 
22) Watanabe Y et al. GlycoPOST realizes FAIR principles for glycomics mass spectrometry data. Nucleic Acids Res 2021;49(D1):D1523-8.
PubMed
23) Tryka KA et al. NCBI's Database of Genotypes and Phenotypes:dbGaP. Nucleic Acids Res 2014;42:D975-9.
PubMed
24) Lappalainen I et al. The European Genome-phenome Archive of human data consented for biomedical research. Nat Genet 2015;47(7):692-5.
PubMed

8. 疾患ゲノム解析I : NGS解析

P.55 掲載の参考文献
1) Ng SB et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-5.
PubMed
2) Varela I et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011;469:539-42.
PubMed
3) Shigemizu D et al. Performance of comparison of four com-mercial human whole-exome capture platforms. Sci Rep 2015;5:12742.
 
4) Yang Y et al. Clincal whole-exome sequencing for the diag-nosis of mendelian disorders. N Engl J Med 2013;369:1502-11.
 
5) Atwal PS et al. Clinical whole-exome sequencing:are we there yet? Genet Med 2014;16(9):717-9.
PubMed
6) Shigemizu D et al. Exome analyses of long QT syndrome reveal candidate pathogenic mutations incalmodulin-inter-acting gene. PLoS One 2015;10(7):e0130329.
 
7) Shigemizu D et al. IMSindel:An accurate intermediate-size indel detection tool incorporating de novo assembly and gapped global-local alignment with split read analysis. Sci Rep 2018;8:5608.
PubMed

9. 疾患ゲノム解析II : GWAS解析

P.59 掲載の参考文献
1) Purcell S et al. PLINK:a tool set for whole-genome associa-tion and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
 
2) Nica AC et al. Expression quantitative trait loci:present and future. Philos Trans R Soc Lond B Biol Sci 2013;368(1620):20120362.
PubMed
3) Lawrenson K et al. Cis-eQTL analysis and functional valida-tion of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun 2015;6:8234.
 
4) Shigemizu D et al. Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease risk. Transl Psychiatry 2021;11(1):151.
PubMed
5) Shigemizu D et al. The construction of risk prediction models using GWAS data and its application to a type 2 diabetes prospective cohort. PLoS One 2014;9(3):e92549.
PubMed
6) Jiang X et al. A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy-results from a Swedish cohort study. Arthri-tis Res Ther 2016;18(1):288.
 
7) Shigemizu D et al. Prognosis prediction model for conver-sion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data. Alzheimers Res Ther 2020;12(1):145.
 
8) Akiyama S et al. JAMIR-eQTL:Japanese genome-wide identification of microRNA expression quantitative trait loci across dementia types. Database(Oxford)2021;2021:baab 072.
 
9) Mitchell AJ, Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment:a pooled analysis J Neurol Neurosurg Psychiatry 2008;79:1386-91.
 

10. 機械学習による薬物応答トランスクリプトームの解析と疾患治療薬の探索

P.65 掲載の参考文献
1) Iorio F et al. J Comput Biol 2009;16:241-51.
PubMed
2) Iorio F et al. Proc Natl Acad Sci USA 2010;107:14621-6.
PubMed
3) Hizukuri Y et al. BMC Med Genomics 2015;8:82.
PubMed
4) Lamb J et al. Science 2006;313:1929-35.
PubMed
5) Dudley JT et al. Sci Transl Med 2011;3:96ra76.
PubMed
6) Sirota M et al. Sci Transl Med 2011;3:96ra77.
PubMed
7) Kunkel SD et al. Cell Metab 2011;13:627-38.
PubMed
8) Jahchan NS et al. Cancer Discov 2013;3:1364-77.
PubMed
9) Kosaka T et al. Cancer Sci 2013;104:1017-26.
PubMed
10) van Noort V et al. Cancer Res 2014;74:5690-9.
PubMed
11) Subramanian A et al. Cell 2017;171:1437-52. e17.
 
12) Iwata M et al. Sci Rep 2017;7:40164.
PubMed
13) Iwata M et al. J Med Chem 2018;61:9583-95.
PubMed
14) Sawada R et al. Sci Rep 2018;8:156.
PubMed
15) Iwata M et al. Bioinformatics 2019;35:i191-9.
PubMed
16) Yuan L et al. ICONIP 2017;222-9.
 
17) Acar E et al. Chemometr Intell Lab Syst 2011;106:41-56.
 
18) Wang Z et al. Nat Commun 2016;7:12846.
PubMed
19) Salentin S et al. Sci Rep 2017;7:11401.
PubMed
20) Xiang D et al. Biochem Biophys Res Commun 2015;464:221-8.
PubMed

11. 画像診断用人工知能 - コンピュータ支援診断 ( CAD )

P.71 掲載の参考文献
1) Liang H et al. Nat Med 2019;25(3):433-8.
PubMed
2) Astore C et al. Sci Rep 2021;11(1):20864.
PubMed
3) Esteva A et al. Nature 2017;542(7639):115-8.
PubMed
4) 土井邦雄. ラジオロジー 2014;23:1-4.
 
5) Watanabe A et al. J Digit Imaging 2019;32(4):625-37.
PubMed
6) Russakovsky O et al. Int J Comput Vis 2015;115:211-52.
 
7) Kurzweil R. Penguin Books;2005.
 
8) Fukushima K. Biol Cybern 1980;36:193-202.
PubMed
9) Sim Y et al. Radiology 2020;294(1):199-209.
PubMed
10) Gu Y et al. Comput Biol Med 2021;137:104806.
PubMed
11) Ardila D et al. Nat Med 2019;25(6):954-61.
PubMed
12) Ishioka M et al. Dig Endosc 2019;31(2):e34-5.
PubMed
13) Mori Y et al. VideoGIE 2019;4(1):7-10.
PubMed
14) Cui M, Zhang DY. Lab Invest 2021;101:412-22.
PubMed
15) Sarwar S et al. NPJ Digit Med 2019;2:28.
PubMed
16) Gulshan V et al. JAMA 2016;316(22):2402-10.
PubMed
17) Poplin R et al. Nat Biomed Eng 2018;2(3):158-64.
PubMed
18) Reardon S. Nature 2019;576(7787):S54-8.
PubMed

12. 臨床におけるバイオインフォマティクス

P.77 掲載の参考文献
1) National Human Genome Research Institute. The Cost of Sequencing a Human Genome. (https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost)
 
2) NCI. The Cancer Genome Atlas Program. (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga)
 
3) Cell Press. Welcome to the Pan-Cancer Atlas. (https://www.cell.com/pb-assets/consortium/pancanceratlas/pancani3/index.html)
 
4) NCI. Harmonized Cancer Datasets. Genomic Data Com-mons Data Portal.(https://portal.gdc.cancer.gov)
 
5) Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature 2013;497(7447):67-73.
 
6) Wortman BG et al. Molecular-integrated risk profile to deter-mine adjuvant radiotherapy in endometrial cancer:evalu-ation of the pilot phase of the PORTEC-4a trial. Gynecol Oncol 2018;151(1):69-75.
 
7) 一般社団法人日本病理学会編. ゲノム研究用・診療用病理組織検体取扱い規程. 羊土社;2019.
 
8) Yoshihara K et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013;4:2612.
PubMed
9) Suda K et al. Clonal expansion and diversification of can-cer-associated mutations in endometriosis and normal endometrium. Cell Rep 2018;24(7):1777-89.
 
10) Suda K et al. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis. Cancer Sci 2020;111(8):3000-9.
PubMed
11) Yachida N et al. Biological significance of KRAS mutant allele expression in ovarian endometriosis. Cancer Sci 2021;112(5):2020-32.
PubMed
12) Yamaguchi M et al. Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epithe-lium. Nat Commun 2022;13(1):943.
 
13) Kakiuchi N, Ogawa S. Clonal expansion in non-cancer tis-sues. Nat Rev Cancer 2021;21(4):239-56.
 
14) Moore L et al. The mutational landscape of normal human endometrial epithelium. Nature 2020;580(7805):640-6.
PubMed

13. プレシジョン・メディシンI - がんゲノム医療

P.82 掲載の参考文献
1) International Cancer Genome Consortium. ICGC Data Por-tal.(https://dcc.icgc.org)
 
2) National Institutes of Health. The Cancer Genome Atlas Pro-gram.(https://tcga-data.nci.nih.gov)
 
3) Cancer Genome Atlas Research Network. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 2013;45:1113-20.
 
4) Babraham Bioinformatics. FastQC:A quality control tool for high throughput sequence data. 2010. (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/)
 
5) Bolger AM et al. Trimmomatic:a flexible trimmer for Illumina sequence data. Bioinformatics 2014;30(15):2114-20.
PubMed
6) GitHub. Lh3/bwa.(https://github.com/lh3/bwa)
PubMed
7) Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie2. Nat Methods 2012;9:357-9.
 
8) Li H et al. The Sequence Alignment/Map format and SAM-tools. Bioinformatics 2009;25(16):2078-9.
PubMed
9) Chen K et al. BreakDancer:an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 2009;6:677-81.
PubMed
10) Rausch T et al. DELLY:structural variant discovery by inte-grated paired-end and split-read analysis. Bioinformatics 2012;28(18):i333-9.
 
11) Chen X et al. Manta:rapid detection of structural variants and indels for germline and cancer sequencing applica-tions. Bioinformatics 2016;32(8):1220-2.
 
12) Cameron DL et al. GRIDSS:sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res 2017;27(12):2050-60.
 
13) Wang K et al. PennCNV:an integrated hidden Markov model designed for high-resolution copy number variation detec-tion in whole-genome SNP genotyping data. Genome Res 2007;17:1665-74.
 
14) Bioconductor. DNAcopy.(https://bioconductor.riken.jp/packages/3.1/bioc/html/DNAcopy.html)
 
15) Nagahashi M et al. Genomic landscape of colorectal cancer in Japan:clinical implications of comprehensive genomic sequencing for precision medicine. Genome Med 2016;8:136.
PubMed
16) Yi JH et al. A retrospective analysis for patients with HER2-positive gastric cancer who were treated with Trastuzumab-based chemotherapy:in the perspectives of ethnicity and histology. Cancer Res Treat 2016;48(2):553-60.
PubMed
17) Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513:202-9.
 
18) Alexandrov LB et al. Signatures of mutational processes in human cancer. Nature 2013;500(7463):415-21.
PubMed

14. プレシジョン・メディシンII - がんゲノミクスの応用

P.89 掲載の参考文献
1) Park HR et al. Acquired resistance to third-generation EGFR tyrosine kinase inhibitors in patients with de novo EGFR T790M-mutant NSCLC. J Thorac Oncol 2021;16(11):1859-71.
PubMed
2) Ng PC, Henikoff S. SIFT:predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31(13):3812-4. (https://sift.bii.a-star.edu.sg)
 
3) Jagadeesh KA et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitiv-ity. Nat Genet 2016;48:1581-6. (http://bejerano.stanford.edu/MCAP/)
 
4) Choi Y, Chan AP. PROVEAN web server:a tool to predict the functional effect of amino acid substitutions and indels. Bio-informatics 2015;31(16):2745-7.(http://provean.jcvi.org)
 
5) Reva B et al. Predicting the functional impact of protein mutations:application to cancer genomics. Nucleic Acids Res 2011;39(17):e118. (http://mutationassessor.org)
 
6) Adzhubei IA et al. A method and server for predicting dam-aging missense mutations. Nat Methods 2010;7(4):248-9. (http://genetics.bwh.harvard.edu/pph2/)
 
7) Rodrigues CH et al. DynaMut:predicting the impact of muta-tions on protein conformation, flexibility and stability. Nucleic Acids Res 2018;46(W1):W350-5. (http://biosig.unimelb.edu.au/dynamut/)
 
8) Bromberg Y, Rost B. SNAP:predict effect of non-synony-mous polymorphisms on function. Nucleic Acids Res 2007;35(11):3823-35. (https://www.rostlab.org/services/snap/)
 
9) Schwarz JM et al. MutationTaster evaluates disease-caus-ing potential of sequence alterations. Nat Methods 2010;7(8):575-6. (https://www.mutationtaster.org)
 
10) Alexandrov LB et al. Signatures of mutational processes in human cancer. Nature 2013;500(7463):415-21. (https://cancer.sanger.ac.uk/cosmic)
 
11) Guinney J et al. The consensus molecular subtypes of colorectal cancer. Nat Med 2015;21(11):1350-6.
PubMed
12) Aderka D et al. Explaining the unexplainable:discrepancies in results from the CALGB/SWOG 80405 and FIRE-3 stud-ies. Lancet Oncol 2019;20(5):e274-83.
 
13) Routy B et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018;359(6371):91-7.
PubMed
14) Gopalakrishnan V et al. Gut microbiome modulates res-ponse to anti-PD-1 immunotherapy in melanoma patients. Science 2018;359(6371):97-103.
 
15) Matson V et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 2018;359(6371):104-8.
PubMed
16) Geller LT et al. Potential role of intratumor bacteria in mediat-ing tumor resistance to the chemotherapeutic drug gem-citabine. Science 2017;357(6356):1156-60.
 
17) Nejman D et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 2020;368(6494):973-80.
PubMed
18) Okuda S et al. Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer. Comput StructBiotechnol J 2021;19:3330-8.
 
19) Kather JN et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med 2019;25(7):1054-6.
PubMed
20) Shimada Y et al. Histopathological characteristics and artifi-cial intelligence for predicting tumor mutational burden-high colorectal cancer. J Gastroenterol 2021;56(6):547-59.
 

15. やってみようバイオインフォマティクス - SNP解析編

P.100 掲載の参考文献
1) Bolger AM et al. Trimmomatic:a flexible trimmer for Illumina sequence data. Bioinformatics 2014;30(15):2114-20.
PubMed
2) Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26(5):589-95.
PubMed
3) McKenna A et al. The Genome Analysis Toolkit:a MapRe-duce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20(9):1297-303.
 
4) Li B et al. RSEM:accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011;12:323.
PubMed
5) Li H et al. The Sequence Alignment/Map format and SAM-tools. Bioinformatics 2009;25(16):2078-9.
PubMed
6) Cingolani P et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff:SNPs in the genome of Drosophila melanogaster strain w1118;iso-2;iso-3. Fly(Austin)2012;6(2):80-92.
PubMed
7) Shigemizu D et al. Performance comparison of four com-mercial human whole-exome capture platforms. Sci Rep 2015;5:12742.
 

16. やってみようバイオインフォマティクス - RNA - seq解析編

P.108 掲載の参考文献
1) Bolger AM et al. Trimmomatic:a flexible trimmer for Illumina sequence data. Bioinformatics 2014;30(15):2114-20.
PubMed
2) Li B et al. RSEM:accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011;12:323.
PubMed
3) Dobin A et al. STAR:ultrafast universal RNA-seq aligner. Bioinformatics 2013;29(1):15-21.
PubMed
4) Love MI et al. Moderated estimation of fold change and dis-persion for RNA-seq data with DESeq2. Genome Biology 2014;15:550.
 
5) Soneson C et al. Differential analyses for RNA-seq:transcript-level estimates improve gene-level inferences[version 1;peer review:2 approved]. F1000Research 2015;4:1521.
 
6) R Core Team(2016). R:A language and environment for statistical computing. R Foundation for Statistical Comput-ing, Vienna, Austria.
 
7) Kim SK et al. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients Mol. Oncol 2014;8(8):1653-66.
PubMed

17. やってみようバイオインフォマティクス - メタ16S解析編

P.116 掲載の参考文献
1) Arumugam M et al. Enterotypes of the human gut microbi-ome. Nature 2011;473:174-80.
 
2) Le Chatelier E et al. Richness of human gut microbiome cor-relates with metabolic markers. Nature 2013;500:541-6.
 
3) Bolyen E et al. Reproducible,interactive,scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019;37:852-7.
PubMed
4) Sayers EW et al. Database resources of the National Center for BiotechnologyInformation. Nucleic Acids Res 2021;49:D10-D17.
PubMed
5) Fukuda A et al. DDBJ update:streamlining submission and access of human data. Nucleic Acids Res 2021;49:D71-D75.
PubMed
6) Harrison PW et al. The European Nucleotide Archive in 2020. Nucleic Acids Res 2021;49:D82-D85.
PubMed
7) Park J et al. Comprehensive analysis of gut microbiota of a healthy population and covariates affecting microbial varia-tion in two large Japanese cohorts. BMC Microbiol 2021;21:151.
 
8) Caporaso JG et al. QIIME allows analysis of high-through-put community sequencing data. Nat Methods 2010;7:335-6.
 
9) Callahan BJ et al. DADA2:High-resolution sample inference from Illumina amplicon data. Nat Methods 2016;13:581-3.
PubMed
10) Klindworth A et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res 2013;41:e1.
PubMed
11) Maidak BL et al. The RDP(Ribosomal Database Project). Nucleic Acids Res 1997;25:109-11.
 
12) DeSantis TZ et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-72.
PubMed

18. やってみようバイオインフォマティクス - エンリッチメント解析編

P.123 掲載の参考文献
1) Dennis G Jr et al. DAVID:Database for annotation, visualiza-tion, and integrated discovery. Genome Biol 2003;4(5):P3.
 
2) UniProt Consortium. UniProt:the universal protein knowledge-base in 2021. Nucleic Acids Res 2021;49(D1):D480-9.
 
3) Raudvere U et al. g:Profiler:a web server for functional enrichment analysis and conversions of gene lists(2019 update). Nucleic Acids Res 2019;47(W1):W191-8.
PubMed
4) Ashburner M et al. Gene ontology:tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25(1):25-9.
PubMed
5) Kanehisa M et al. KEGG:integrating viruses and cellular organisms. Nucleic Acids Res 2021;49:D545-51.
PubMed
6) Jassal B et al. The reactome pathway knowledgebase. Nucleic Acids Res 2020;48(D1):D498-503.
PubMed
7) Subramanian A et al. Gene set enrichment analysis:a knowl-edge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102(43):15545-50.
 

書評

最近チェックした商品履歴

Loading...